SCHEMBL23637606

SCHEMBL23637606

CCc1cccc(N2CCNC2)c1Cl

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 11/20 0.83
▸ DRD3 P35462 11/20 0.83
▸ DRD4 P21917 7/20 0.83
▸ HTR1A P08908 4/20 0.83
▸ HTR2A P28223 4/20 0.83
▸ HTR2C P28335 4/20 0.83
▸ ADRB1 P08588 4/20 0.51
▸ OPRM1 P35372 3/20 0.44
▸ HTR3E A5X5Y0 1/20 0.41
▸ HTR3B O95264 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ HTR2B P41595 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29799509 0.91 DRD2 (1.00) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL19358657 0.91 DRD2 (1.00) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL17066480 0.79 DRD2 (0.80) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL27635353 0.76 HTR1A (0.74) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24683684 0.76 DRD2 (1.00) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL14397163 0.76 HTR1A (0.74) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL335802 0.75 HTR1A (0.73) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL31561598 0.75 HTR1A (0.73) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL28078181 0.75 HTR1A (0.73) DRD2DRD3DRD4HTR1AHTR2A
Hydrochloric Acid SCHEMBL11552605 0.75 HTR1A (0.68) DRD2DRD3DRD4HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3848351-A1 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF The United States of America, as represented by The Secretary, Department of Health and Human Services (US) 2021-07-14 — — EP disclosed
Send feedback